EUVIMEDEUVIMED entdecken
Open Access

Lipid nanoparticles for mRNA delivery in brain via systemic administration

Dinglingge Cao iD, Xucheng Hou iD, Chang Wang iD, Siyu Wang, Zhengwei Liu iD, Meng Tian iD, Kaiyuan Guo iD, Haoyuan Li, Diana D Kang, Yichen Zhong iD, Yonger Xue iD, Changyue Yu iD und 2 weitere

Science Advances · 15.08.2025 · 11 (33)

DOI: 10.1126/sciadv.adw0730 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 15.08.2025. Verfasst von Dinglingge Cao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Icahn Genomics Institute, Precision Immunology Institute, Department of Immunology and Immunotherapy, Department of Oncological Sciences, Tisch Cance…. Hauptthemen laut MEDLINE: RNA, Messenger, Nanoparticles, Brain, Lipids. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efficient delivery of messenger RNA (mRNA) to the brain via systemic administration remains a challenge, primarily due to the blood-brain barrier. To address this challenge, we incorporated SR-57227, a ligand of serotonin [5-hydroxytryptamine type 3 (5-HT 3 )] receptor, into the design of ionizable lipids to develop lipid nanoparticles (LNPs) for systemic mRNA delivery to the brain. OS4T LNP was identified as an optimized formulation based on multiple assays. Following systemic administration, OS4T LNP achieved over a 50-fold increase in mRNA translation within brain tissues compared to US Food and Drug Administration–approved Onpattro LNPs (DLin-MC3-DMA). In an orthotopic glioblastoma (GBM) mouse model, engineered interleukin-12 mRNA–loaded OS4T LNPs significantly suppressed tumor growth and improved overall survival. This study demonstrates OS4T LNP as a promising platform for brain mRNA delivery and highlights its potential for treating GBM and other central nervous system disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, MessengerNanoparticlesBrainLipidsAnimalsMiceHumansGlioblastomaBrain NeoplasmsCell Line, TumorDrug Delivery SystemsInterleukin-12Liposomes

Substanzen

RNA, MessengerLipidsLipid NanoparticlesInterleukin-12Liposomes

Autor:innen und Institutionen

  • Icahn Genomics Institute, Precision Immunology Institute, Department of Immunology and Immunotherapy, Department of Oncological Sciences, Tisch Cancer Institute, Friedman Brain Institute, Biomedical Engineering and Imag…
  • Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA.
  • Center for Electron Microscopy and Analysis, The Ohio State University, Columbus, OH, USA.

ORCID-Profile: Dinglingge Cao, Xucheng Hou, Chang Wang, Zhengwei Liu, Meng Tian, Kaiyuan Guo, Yichen Zhong, Yonger Xue, Changyue Yu, Yizhou Dong

Zitieren

APA

Cao, D., Hou, X., Wang, C., Wang, S., Liu, Z., Tian, M., Guo, K., Li, H., Kang, D. D., Zhong, Y., Xue, Y., Yu, C., Deng, B., & Dong, Y. (2025). Lipid nanoparticles for mRNA delivery in brain via systemic administration. Science Advances, 11(33). https://doi.org/10.1126/sciadv.adw0730

Vancouver

Cao D, Hou X, Wang C, Wang S, Liu Z, Tian M, et al. Lipid nanoparticles for mRNA delivery in brain via systemic administration. Science Advances. 2025;11(33). doi:10.1126/sciadv.adw0730

BibTeX
@article{Cao2025,
  author = {Cao, Dinglingge and Hou, Xucheng and Wang, Chang and Wang, Siyu and Liu, Zhengwei and Tian, Meng and Guo, Kaiyuan and Li, Haoyuan and Kang, Diana D and Zhong, Yichen and Xue, Yonger and Yu, Changyue and Deng, Binbin and Dong, Yizhou},
  title = {Lipid nanoparticles for mRNA delivery in brain via systemic administration},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {33},
  doi = {10.1126/sciadv.adw0730}
}
Kostenlos starten →